2-carboxyarabinitol 1-phosphate and Disease Models, Animal

2-carboxyarabinitol 1-phosphate has been researched along with Disease Models, Animal in 2 studies

*Disease Models, Animal: Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases. [MeSH]

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (50.00)	2.80

Authors

Authors	Studies
Chen, GW; Cho, MH; Churchwell, MI; Doerge, DR; Helferich, WG; Hergenrother, PJ; Hoagland, MS; Hwang, SK; Jin, H; Kwon, JT; Pearson, JM; Putt, KS; Sandhorst, JS	1
Abrams, RPM; Bachani, M; Balasubramanian, A; Brimacombe, K; Dorjsuren, D; Eastman, RT; Hall, MD; Jadhav, A; Lee, MH; Li, W; Malik, N; Nath, A; Padmanabhan, R; Simeonov, A; Steiner, JP; Teramoto, T; Yasgar, A; Zakharov, AV	1

Other Studies

2 other study(ies) available for 2-carboxyarabinitol 1-phosphate and Disease Models, Animal

Article	Year
Small-molecule activation of procaspase-3 to caspase-3 as a personalized anticancer strategy. Nature chemical biology, 2006, Volume: 2, Issue:10 Topics: Administration, Oral; Animals; Antineoplastic Agents; Apoptosis; Caspase 3; Caspases; Cell Line, Tumor; Cell Proliferation; Disease Models, Animal; Dose-Response Relationship, Drug; Enzyme Activation; Humans; Hydrazones; In Vitro Techniques; Mice; Mice, Nude; Molecular Structure; Piperazines; Signal Transduction; Structure-Activity Relationship; Time Factors; Xenograft Model Antitumor Assays	2006
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors. Proceedings of the National Academy of Sciences of the United States of America, 2020, 12-08, Volume: 117, Issue:49 Topics: Animals; Antiviral Agents; Artificial Intelligence; Chlorocebus aethiops; Disease Models, Animal; Drug Evaluation, Preclinical; High-Throughput Screening Assays; Immunocompetence; Inhibitory Concentration 50; Methacycline; Mice, Inbred C57BL; Protease Inhibitors; Quantitative Structure-Activity Relationship; Small Molecule Libraries; Vero Cells; Zika Virus; Zika Virus Infection	2020

Article

Year

Small-molecule activation of procaspase-3 to caspase-3 as a personalized anticancer strategy.

Nature chemical biology, 2006, Volume: 2, Issue:10

Topics: Administration, Oral; Animals; Antineoplastic Agents; Apoptosis; Caspase 3; Caspases; Cell Line, Tumor; Cell Proliferation; Disease Models, Animal; Dose-Response Relationship, Drug; Enzyme Activation; Humans; Hydrazones; In Vitro Techniques; Mice; Mice, Nude; Molecular Structure; Piperazines; Signal Transduction; Structure-Activity Relationship; Time Factors; Xenograft Model Antitumor Assays

2006

Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.

Proceedings of the National Academy of Sciences of the United States of America, 2020, 12-08, Volume: 117, Issue:49

Topics: Animals; Antiviral Agents; Artificial Intelligence; Chlorocebus aethiops; Disease Models, Animal; Drug Evaluation, Preclinical; High-Throughput Screening Assays; Immunocompetence; Inhibitory Concentration 50; Methacycline; Mice, Inbred C57BL; Protease Inhibitors; Quantitative Structure-Activity Relationship; Small Molecule Libraries; Vero Cells; Zika Virus; Zika Virus Infection

2020